A Study of Mircera for the Treatment of Anemia in Dialysis Patients

NCT00077597 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: epoetin
DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche